← Back to Patent Explorer
US5665728A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of treating hyperproliferative vascular disease

Assignee: Wyeth LLC
•
Filing: 1995-05-26
•
Granted: 1997-09-09
•
Expires: 2015-05-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention provides a method of preventing or treating hyperproliferative vascular disease in a mammal by administering an antiproliferative effective amount of rapamycin alone or in combination with mycophenolic acid.

Inventors

  • 👤 Randall Ellis Morris
  • 👤 Clare Robert Gregory

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 05:18
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/70; A61K31/7042; A61K31/7052; A61K31/706; A61K31/395; A61K31/435; A61K31/4353; A61K31/436; A61K45/00; A61K45/06; A61P; A61P7/00; A61P7/02; A61P9/00; A61P9/10

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 70 words
A method of treating a hyperproliferative vascular disease selected from the group consisting of intimal smooth muscle cell proliferation, restenosis, and vascular occlusion, wherein the intimal smooth muscle cell proliferation, restenosis, or vascular occlusion is caused by an infectious disorder, hypothermia, or irradiation, which comprises administering an antiproliferative effective amount of rapamycin to said mammal orally, parenterally, intravascularly, intranasally, intrabronchially, transdermally, rectally, or via a vascular stent impregnated with rapamycin.
Claim 2
Independent Claim 70 words
A method of treating a hyperproliferative vascular disease selected from the group consisting of intimal smooth muscle cell proliferation, restenosis, and vascular occlusion, wherein the intimal smooth muscle cell proliferation, restenosis, or vascular occlusion is caused by an infectious disorder, hypothermia, or irradiation, which comprises administering an antiproliferative effective amount of rapamycin to said mammal orally, parenterally, intravascularly, intranasally, intrabronchially, transdermally, rectally, or via a vascular stent impregnated with rapamycin.
Claim 3
Independent Claim 76 words
A method of treating a hyperproliferative vascular disease selected from the group consisting of intimal smooth muscle cell proliferation, restenosis, and vascular occlusion, wherein the intimal smooth muscle cell proliferation, restenosis, or vascular occlusion is caused by vascular catheterization, vascular scraping, percutaneous transluminal/coronary angioplasty, vascular surgery, or laser treatment, which comprises, administering an antiproliferative effective amount of rapamycin to said mammal orally, parenterally, intravascularly, intranasally, intrabronchially, transdermally, rectally, or via a vascular stent impregnated with rapamycin.
Claim 4
Independent Claim 76 words
A method of treating a hyperproliferative vascular disease selected from the group consisting of intimal smooth muscle cell proliferation, restenosis, and vascular occlusion, wherein the intimal smooth muscle cell proliferation, restenosis, or vascular occlusion is caused by vascular catheterization, vascular scraping, percutaneous transluminal/coronary angioplasty, vascular surgery, or laser treatment, which comprises, administering an antiproliferative effective amount of rapamycin to said mammal orally, parenterally, intravascularly, intranasally, intrabronchially, transdermally, rectally, or via a vascular stent impregnated with rapamycin.

References Cited (Backward Citations)

US3929992A Cited
US4885171A Cited
EP0401747A2 Cited
US5100899A Cited
US5078999A Cited
US5080899A Cited
US5516781A Cited
US5288711A Cited
US5256790A Cited
US5252579A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-09-08 2001-03-10 2001-09-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-09-08 2005-03-10 2005-09-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-09-08 2009-03-10 2009-09-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag